人工智能驱动的替代医学：药物发现和再利用的新方法

arXiv - QuanBio - Biomolecules Pub Date : 2024-07-02 DOI:arxiv-2407.02126

Oleksandr Bilokon, Nataliya Bilokon, Paul Bilokon

{"title":"人工智能驱动的替代医学：药物发现和再利用的新方法","authors":"Oleksandr Bilokon, Nataliya Bilokon, Paul Bilokon","doi":"arxiv-2407.02126","DOIUrl":null,"url":null,"abstract":"AIAltMed is a cutting-edge platform designed for drug discovery and\nrepurposing. It utilizes Tanimoto similarity to identify structurally similar\nnon-medicinal compounds to known medicinal ones. This preprint introduces\nAIAltMed, discusses the concept of `AI-driven alternative medicine,' evaluates\nTanimoto similarity's advantages and limitations, and details the system's\narchitecture. Furthermore, it explores the benefits of extending the system to\ninclude PubChem and outlines a corresponding implementation strategy.","PeriodicalId":501022,"journal":{"name":"arXiv - QuanBio - Biomolecules","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing\",\"authors\":\"Oleksandr Bilokon, Nataliya Bilokon, Paul Bilokon\",\"doi\":\"arxiv-2407.02126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AIAltMed is a cutting-edge platform designed for drug discovery and\\nrepurposing. It utilizes Tanimoto similarity to identify structurally similar\\nnon-medicinal compounds to known medicinal ones. This preprint introduces\\nAIAltMed, discusses the concept of `AI-driven alternative medicine,' evaluates\\nTanimoto similarity's advantages and limitations, and details the system's\\narchitecture. Furthermore, it explores the benefits of extending the system to\\ninclude PubChem and outlines a corresponding implementation strategy.\",\"PeriodicalId\":501022,\"journal\":{\"name\":\"arXiv - QuanBio - Biomolecules\",\"volume\":\"45 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - QuanBio - Biomolecules\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2407.02126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - QuanBio - Biomolecules","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2407.02126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

AIAltMed 是专为药物发现和再利用而设计的尖端平台。它利用谷本相似性来识别与已知药用化合物结构相似的药用化合物。这份预印本介绍了AIAltMed，讨论了 "人工智能驱动的替代医学 "这一概念，评估了谷本相似性的优势和局限性，并详细介绍了该系统的架构。此外，它还探讨了将该系统扩展到包括 PubChem 的好处，并概述了相应的实施策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing

AIAltMed is a cutting-edge platform designed for drug discovery and repurposing. It utilizes Tanimoto similarity to identify structurally similar non-medicinal compounds to known medicinal ones. This preprint introduces AIAltMed, discusses the concept of `AI-driven alternative medicine,' evaluates Tanimoto similarity's advantages and limitations, and details the system's architecture. Furthermore, it explores the benefits of extending the system to include PubChem and outlines a corresponding implementation strategy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

arXiv - QuanBio - Biomolecules

自引率

0.00%

发文量